Vital Sign Monitoring
11
3
3
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (11)
Continuous Monitoring of Vital Signs at Home (WARD HOME II)
Continuous Vital Sign Monitoring Versus Routine Spot-checks in Patients After Non-cardiac Surgery
Effect of Nicotine Pouches on The Underlying Normal Electrocardiogram
Effect of ANNE One-Wellue Device Array Use on Staff Bedside Vital Sign Measurement Activity
The Effect of Two Different Bathing Methods on Vital Signs and Comfort in PICU:Bath Trial
Effect Of Local Cold Applıcatıon On Paın and Vıtal Sıgns Durıng Port Catheter Needle Insertıon
Continuous and Wireless Vital Sign Monitoring in Patients at Home After Acute Medical Admission
Pilot Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients
Pilot Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients Patients
Pilot Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients
Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients Patients